期刊文献+

对急性冠状动脉综合征抗血小板治疗的药物优化研究 被引量:5

下载PDF
导出
摘要 急性冠状动脉综合征(acute coronary syndrome,ACS)是以冠状动脉粥样硬化斑块破裂或糜烂,继发完全或不完全闭塞性血栓,形成为病理基础的一组临床综合征。包括不稳定心绞痛(unstable angina,UA)、非ST段抬高心肌梗死(non-ST—elevationmyocardialinfarction,NSTEMI)和ST段抬高心肌梗死(ST—elevationmyocardialinfarction,STEMI)的一系列临床病征。长期的临床实践发现,许多患者的临床症状各异,
出处 《心肺血管病杂志》 CAS 2011年第6期558-560,共3页 Journal of Cardiovascular and Pulmonary Diseases
  • 相关文献

参考文献18

  • 1郝恒剑,胡少东,许骥.急性心肌梗死直接介入治疗后无复流现象形成因素分析[J].心肺血管病杂志,2009,28(1):32-35. 被引量:9
  • 2周玉杰,闫振娴.经皮冠状动脉介入治疗围手术期抗凝新视点[J].心肺血管病杂志,2008,27(1):52-54. 被引量:10
  • 3Rajan L,Moliterno DJ.Beyond Aspirin and Clopidogrel:Is there a need for additional antiplatelet therapy in ACS? Curr Cardiol Rep,2011,13:303-311.
  • 4Van Dooren A A ,Muller B W. Inter. J. Pharm.,1984,20:217-233
  • 5Eikelboom JW,Mehts SR,Anand SS,et al.Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.Circulation,2006,114:774-782.
  • 6Rao SV,Jollis JG,Harrington RA,et al.Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.JAMA,2004,292:1555-1562.
  • 7Rao SV,O'Grady K,Pieper KS,et al.Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.Am J Cardiol,2005,96:1200-1206.
  • 8Subherwal S,Bach RG,Chen AY,et al.Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction:the CRUSADE(Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines)Bleeding Score.Circulation,2009,119:1873-1 882.
  • 9马长生,高凌云.心房纤颤患者脑卒中的预防-抗凝与抗血小板治疗[J].心肺血管病杂志,2010,29(3):245-247. 被引量:19
  • 10李江,刘文娴.阿司匹林抵抗的现状及展望[J].心肺血管病杂志,2009,28(1):61-63. 被引量:8

二级参考文献72

  • 1颜东,吕树铮,刘文娴.阿司匹林抵抗[J].心肺血管病杂志,2004,23(3):186-188. 被引量:2
  • 2陈哲,张健,李春盛,夏成青,齐曼.辛伐他汀对老年血脂异常患者的血脂及血小板活化功能的影响[J].医师进修杂志,2005,28(1):36-37. 被引量:6
  • 3张妍,梁静,周玉杰,谢英,李艳芳,赵迎新,刘宇扬.通心络有效干预阿司匹林抵抗现象的临床观察[J].中国综合临床,2006,22(9):778-779. 被引量:12
  • 4Tanaka A,Kawarahayashi T,Nishibori Y,et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction.Circulation,2002,105:2148-2152.
  • 5Brosh D,Assali AR,Maser A,et al.Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.Am J Cardiol 2007,99:442-445.
  • 6Singh M,Mathew V,Garratt KN,et al.Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic.Am J Med,2000,108:187-192.
  • 7Kirma C,Izgi A,Dundar C,et al.Clinical and Procedural Predictors of No-Reilow Phenomenon After Primary Percutaneous Coronary Interventions.Ciro J,2008,72:716-721.
  • 8Isaaz K,Robin C,Cerisier A,et al.A new approach of primary angioplasty for ST-elevation acute myocardial infarction based on minimalist immediate mechanical intervention.Coron Artery Dis,2006,17:261-269.
  • 9De Luca G,Ernst N,Zijlstra F,et al.Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.J Am Coll Cardiol,2004,43:1363-1367.
  • 10Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes.Circulation,2003,107:1497-1501.

共引文献45

同被引文献33

  • 1张贤,都伟,王云英.高龄急性心肌梗死的临床特征与短期预后研究[J].临床误诊误治,2004,17(6):381-382. 被引量:2
  • 2郝卫军,司全金,李小鹰.老年心血管疾病患者应用不同剂量阿司匹林抗血小板治疗的临床研究[J].中国临床保健杂志,2006,9(3):210-212. 被引量:4
  • 3韩兰唐,赵德友,唐学弘,肖月.无胸痛急性心肌梗死268例临床特征分析[J].军事医学科学院院刊,2006,30(3):248-249. 被引量:2
  • 4White HD, Aylward PE, Huang Z, et al. Mortality and morbidi- ty remain high despite captopril and/or valsartan therapy in elder- ly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsar- tan in Acute Myocardial Infarction Trial. Circulation ,2005,112: 3391-3399.
  • 5中华医学会心血管病学分会,中华心血管病杂志编辑委员会,推荐在我国采用心肌梗死全球统-定义.中华心血管病杂志,2008,36:867~69.
  • 6Gottlieb S, Behar S, Hod H, et al. Trends in management hospi- tal and long-term outcomes of elderly patients with acute myocar- dial infarction. AJM ,2007,120:90-97.
  • 7Di-yi Hu, Chang-yu Pan, Jin-ming Yu. Editor's choice : The re- lationship beteew coronary artery disease and abnormal glu- cose regulation in China: the China heart Survey. Eur Heart J, 2006,27 : 2573-2579.
  • 8Charytan DM, Setoguchi S, Solomon DH, et al. Clinical presen- tation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease. Kidney Int, 2007, 71 : 938-945.
  • 9Aradi D, Komocsi A, Vorobcsuk A, et al. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coro- nary intervention : a systematic review and meta-analysis. Thromb Haemost,2013 ,109 :93-101.
  • 10Ferraris V, Ferraris S, Molitemo D, et al. The Society of Tho- racic Surgeons practice guideline series: aspirin and other anti- platelet agents during operative coronary revascularization ( exec- utive summary). Ann Thorac Surg, 2005,79 : 1454-1461.

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部